This report contains market size and forecasts of Point-of-Care Genetic Testing in Global, including the following market information:
Global Point-of-Care Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Point-of-Care Genetic Testing market was valued at 6486.3 million in 2021 and is projected to reach US$ 7719.1 million by 2028, at a CAGR of 2.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
POCT Cancer Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point-of-Care Genetic Testing include Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US), Cepheid (US), IQuum (US), Biocartis (Switzerland), Idaho Technologies (US), Optigene (UK) and Lumora (UK). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point-of-Care Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point-of-Care Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Point-of-Care Genetic Testing Market Segment Percentages, by Type, 2021 (%)
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Global Point-of-Care Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Point-of-Care Genetic Testing Market Segment Percentages, by Application, 2021 (%)
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
Global Point-of-Care Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Point-of-Care Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point-of-Care Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Point-of-Care Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)